Purchase Order HT001425P0125
Award Date
6/20/25
Potential Completion Date
6/27/25
Potential Value
$24K
Federal Agency
Defense Health Agency
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Northeast Area Division of a civilian federal agency to Illumina, Inc., a leading provider of genetic sequencing technologies and services. The $24,752.43 contract is for the purchase of supplies used to operate Illumina's sequencing instruments, which will be used to sequence DNA samples. The contract has a period of performance through May 2025 and does not utilize any set-aside designations. Illumina holds multiple Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the National Institute on Aging (NIA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of goods headquartered in San Diego, California. The $88,350.98 contract is for the procurement of Illumina's NovaSeq X Series 1.5B and 10B reagent kits, which are used in the company's advanced DNA and RNA sequencing platforms. The contract has an ultimate completion date of November 21, 2025. Illumina is a leading provider of genetic...
This is a firm fixed price delivery order contract valued at $242,110.64 awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of Illumina reagents to support the agency's sequencing and genomic analysis needs, without any set-aside designation. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing systems and related products and...
This is a $19,812.90 firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, a civilian federal agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and related products. The contract has an ultimate completion date of August 3, 2026 and was awarded on August 4, 2025. No set-aside designation was used. Illumina, a leading provider of DNA and RNA sequencing technologies, will deliver a range...
This is a firm fixed price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $154,828.40 contract is for the purchase of reagents to support MEDCOM's genomic analysis and sequencing capabilities. Illumina has previously received other federal contracts and subcontracts from agencies like the National Institutes of Health, Centers for Disease Control, and Department of Veterans Affairs to provide...
This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
This firm fixed-price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of Urinary Pathogen ID/AMR Enrichment Kits. The $61,848.39 contract has a period of performance through September 30, 2024 and will support the use of government-owned Illumina MiSeq sequencing instruments at Tripler Army Medical Center in Hawaii. The award was made on a sole source basis under the simplified acquisition...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $581,761.93, is for the provision of support plans and reagent kits for the NextSeq equipment located at the Walter Reed Army Institute of Research (WRAIR) facility in Silver Spring, Maryland. The contract has an ultimate completion date of October 1, 2024....
This is a Firm Fixed Price Delivery Order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genetic sequencing technologies. The contract, valued at $39,010.14, is for the provision of Illumina's reagent chemistry kits. The contract has an ultimate completion date of September 30, 2023. Illumina is a key technology provider for federal scientific and diagnostic research initiatives, holding a $45 million Indefinite Delivery Contract with...
This is a firm fixed price delivery order contract awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract has a ceiling value of $473,964.67 and is for the provision of various Illumina reagents, with a period of performance through October 28, 2015. This appears to be part of a larger Indefinite Delivery Contract that Illumina holds with the Department of the Navy Bureau of...